Innovation and Equity Discussed at 24th New York Health Forum
The 24th conference of the New York Health Forum unfolded on March 28, 2024 with an air of anticipation, drawing together a diverse array...
top of page
Search
Prestigious Health Equity Award Presented by New York Health Forum
What is the NYHF Health Equity Award? Health disparity has existed universally throughout civilizations since the time of Hippocrates of...
BOOK REVIEW, The AI Revolution in Medicine: GPT-4 and Beyond
In 2022, ChatGPT amazed millions with its abilities but also had some strange quirks. Now, GPT-4 is here, smarter and more accurate,...
Chronic Hepatitis B (CHB) in the United States
Hepatitis B Virus (HBV)is a leading cause of chronic liver diseases, causing cirrhosis and hepatocellular carcinoma (HCC). Approximately...
Stomach (Gastric) Cancer Disparities in the United States
Gastric cancer (GC) is the fifth most common form of cancer worldwide. In 2020, there were approximately 1.1 million new cases reported,...
CDC Recommendations - U.S. 2023:Screening and Testing for Hepatitis B Virus Infection
Chronic hepatitis B virus (HBV) infection can lead to substantial morbidity and mortality. Although treatment is not considered curative,...
Asia Rising at the 2023 BIO International Convention
The 2023 BIO International Convention held in June welcomed more than 20,000 biotechnology and pharma leaders from 73 countries in...
Syntekabio's STB CLOUD is Transforming the Biopharma Industry
BiopharmaTrend.com, one of the top 10 biopharma online news sites, published a timely interview with Syntekabio CEO Jongson Jung about...
K-Blockbuster Project Companies
K-Blockbuster project is a special initiative of Korea Health Industry Development Institute (KHIDI) to support Korean biopharma...
Biotech Company's Innovative Drug Gives Cancer Patients Hope as New Therapy for Oral Mucositis
Enzychem Lifesciences recently announced positive results for its lead compound EC-18 in chemoradiation-induced oral mucositis (CRIOM)...
bottom of page